Inflexion has taken a minority stake in French nail care brand Manucurist, marking its first outside investment in the company. The founders retain majority ownership, and financial terms were not disclosed, though L’Informé previously reported the deal valued Manucurist at about €300m, beating bids from Advent International and Verlinvest. Alantra served as exclusive financial adviser.

Founded in 2016, Manucurist produces plant-based, vegan nail products and at-home LED gel manicure kits, selling across DTC, retail, pharmacy, and marketplace channels in over 40 countries. The brand expects $119m in revenue this year. Inflexion will support international expansion, especially in the US, broaden retail distribution, and drive digital and marketplace growth, while also investing in team, systems, and new products.

Tom Pemberton, Inflexion’s head of Enterprise and Consumer, praised Manucurist as a “brilliant founder-led brand” that disrupted the market through innovation. The deal mirrors Inflexion’s prior success with Medik8, where sales quadrupled and headcount tripled before L’Oréal acquired a majority stake in 2025. Founder and co-CEO Gaëlle Lebrat Personnaz aims to double the business in four to five years and may later sell to a strategic buyer, calling Inflexion a partner who shares that vision.